mGem: Applying microbiome therapeutic learnings to next-generation agricultural bioproducts.
Holmes EC
Soil Health
PubMedSame scientific advances that gave us cutting-edge probiotic therapies for humans could soon lead to safer, smarter microbial soil treatments that help your garden thrive with fewer chemical pesticides and fertilizers.
Researchers studying the tiny microbes living in our guts have learned a lot about how to get beneficial bacteria to settle in and do their job without causing harm. This new paper argues that farmers and plant scientists should borrow those same ideas to create better microbial products for crops — think of it like developing 'probiotics for plants.' By sharing knowledge between human medicine and agriculture, scientists believe we can create tools that improve plant health, boost harvests, and protect ecosystems at the same time.
Key Findings
Human microbiome therapeutics research has developed advanced strategies for microbial colonization and immune interaction that have not yet been fully applied to agricultural bioproducts.
The paper identifies three specific engineering areas — colonization, immune modulation, and biosafety — from human medicine that can directly guide the design of next-generation crop microbiome products.
Greater interdisciplinary collaboration between human health and agricultural microbiome researchers is identified as the critical bottleneck limiting the translation of microbiome science into real-world bioproducts.
chevron_right Technical Summary
Scientists are proposing that breakthroughs from human gut microbiome medicine — like how bacteria colonize our bodies and interact with our immune system — can be directly applied to develop better microbial products for crops and soil health.
Abstract Preview
Biological discoveries in plant and human systems have long advanced our understanding of how signaling, metabolism, and immunity shape cross-kingdom interactions. Building on this rich history of ...
open_in_new Read full abstract on PubMedAbstract copyright held by the original publisher.
Was this useful?
Chloroplast Genome Editing Eliminates Gluten Immunogenicity in Triticum aestivum
It could mean that people with celiac disease — roughly 1 in 100 worldwide — may one day safely eat bread made from real wheat, without sacrificing the taste...